Quali sono gli orari di apertura?

Lunedì 09:00 - 18:00 Martedì 09:00 - 18:00 Mercoledì 09:00 - 18:00 Giovedì 09:00 - 18:00 Venerdì 09:00 - 18:00

Haematologica

Casa
Italia
Pavia
Haematologica

www.haematologica.org publishes novel findings in basic, clinical and translational hematology research. Impact Factor (JCR) 7.116 (7th of 76)

Haematologica/The Hematology Journal (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435) publishes peer-reviewed papers across all areas of experimental and clinical hematology. The journal is owned by a non-profit organization, the Ferrata Storti Foundation, and serves the scientific community strictly following the International Committee of Medical Journal Editors (ICMJE, www.icmje.org) recommendations on publication ethics policies for medical journals. Haematologica was founded in 1920 by Adolfo Ferrata

30/03/2026

ZMYND11::MBTD1 is an extremely rare but recurrent cytogenetic abnormality previously reported in approximately ten cases of acute myeloid leukemia (AML).
A new case series describes clinical and biological characteristics and suggests defining a new distinct subtype of AML with ZMYND11::MBTD1 rearrangement that may warrant recognition as a separate entity under the category of “other rare recurrent genetic abnormalities” in future AML classification systems.
https://haematologica.org/article/view/13008

28/03/2026

Unusual dermatological findings can provide important diagnostic clues in myeloid neoplasms. This report describes granuloma annulare-like pseudohistiocytosis as a potential manifestation associated with ETV6::SYK-rearranged myeloid neoplasm with eosinophilia, highlighting the relevance of clinicopathological recognition in rare molecular entities.
https://haematologica.org/article/view/13004

26/03/2026

Antibiotic therapy and bronchus-associated lymphoid tissue lymphoma.
The relationship between infection and lymphomagenesis continues to shape therapeutic strategies in indolent lymphomas. A report of a case of bronchus-associated lymphoid tissue lymphoma in the context of Tropheryma whipplei infection explores the potential impact of targeted antimicrobial treatment on disease management.
https://haematologica.org/article/view/13014

24/03/2026

Therapeutic options for children with acquired aplastic anemia continue to evolve.
A new study evaluates the safety and efficacy of romiplostim in pediatric patients who are naïve to immunosuppressive therapy, addressing an important question about treatment strategies and early disease management in this vulnerable population.
https://haematologica.org/article/view/12189

22/03/2026

Ovarian tissue autotransplantation in acute leukemia.
Fertility preservation is an increasingly important issue for patients with acute leukemia. A new study examines ovarian tissue autotransplantation as a strategy to restore fertility, addressing the complex balance between oncological safety and reproductive outcomes in leukemia survivors.
https://haematologica.org/article/view/12173

20/03/2026

Unrelated donor selection for ALL transplantation in the PTCy era.
Post-transplant cyclophosphamide (PTCy) helps to redefine donor choice in allogeneic transplantation. In this analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, investigators evaluate key considerations when selecting unrelated donors for patients with acute lymphoblastic leukemia, addressing a central question in contemporary transplant practice.
https://haematologica.org/article/view/12195

17/03/2026

Can we refine outcome prediction after transplant? Donor selection remains a key challenge in allogeneic hematopoietic stem cell transplantation. A new study explores how integrating high-resolution killer cell immunoglobulin-like receptor (KIR) genotyping may enhance our understanding of immune interactions after transplant and improve outcome prediction. The findings raise important questions about how immunogenetic profiling could shape future transplant strategies.
https://haematologica.org/article/view/12166

15/03/2026

Transplant-associated thrombotic microangiopathy (TMA) is a serious complication occurring after hematopoietic stem cell transplantation and is driven by endothelial damage and complement activation. A new study investigates the role of KLF4 in regulating endothelial responses under these conditions, offering new mechanistic insight into vascular injury after transplantation, and raises questions about future therapeutic strategies.
doi.org/10.3324/haematol.2025.287676

12/03/2026

Caffeine is one of the most widely consumed psychoactive compounds worldwide, making it one of the most pervasive modulators of systemic and cellular physiology. A new study evaluates the impact of caffeine on the quality of stored red blood cells (RBC) and post-transfusion circulatory parameters. Interestingly, this psychoactive agent negatively affects RBC transfusion quality.
https://haematologica.org/article/view/12261

10/03/2026

The identification of patients with acute myeloid leukemia (AML) who may have resistant disease when treated with standard induction chemotherapy is still challenging: Murphy and colleagues present the first prospective, multicenter study aiming to evaluate the prognostic value of the leukemic stem cell 17-gene (LSC17) score in patients with newly diagnosed AML.
https://haematologica.org/article/view/12171

07/03/2026

Perspective Articles: Acute leukemia of ambiguous lineage (ALAL) is a rare and high-risk leukemia lacking clear lineage differentiation, including mixed phenotype acute leukemia and acute undifferentiated leukemia. This review discusses how recent genetic, epigenetic, and metabolic insights are reshaping the diagnosis, classification, and risk stratification, while highlighting emerging targeted therapeutic strategies and persistent clinical challenges. Despite evolving WHO and ICC frameworks, major questions remain regarding optimal therapy selection, minimal residual disease monitoring, and transplantation decisions in ALAL.
https://haematologica.org/article/view/12929

04/03/2026

Review article: An overview of the clinical landscape and diagnostic strategies for telomere biology disorders, highlighting the role of telomere dysfunction in cancer development and clonal hematopoiesis, and discussing emerging therapeutic approaches. The review underscores the importance of individualized, multidisciplinary management to optimize patients’ outcomes.
https://haematologica.org/article/view/12905

Indirizzo

Via Giuseppe Belli 4
Pavia
27100

Orario di apertura

Lunedì	09:00 - 18:00
Martedì	09:00 - 18:00
Mercoledì	09:00 - 18:00
Giovedì	09:00 - 18:00
Venerdì	09:00 - 18:00

Telefono

+39038227129

Sito Web

http://www.haematologica.org/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Haematologica pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Haematologica:

Scelte rapide

Promuovere

Vitaminstore Pavia
Viale partigiani 28

Vuoi che la tua studio sia il Clinica più quotato a Pavia?